{"nct_id":"NCT05052801","title":"Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-03-07","start_date_type":"ACTUAL","primary_completion_date":"2025-06-20","primary_completion_date_type":"ACTUAL","completion_date":"2026-06-20","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}